Extract to table

1 — Defined Terms All capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to them in the MCTA

In addition, the following definitions shall apply to this Agreement: (a) "MCTA" means that certain Master Clinical Trial Agreement dated June 28, 2023, between Penterra Pharmaceuticals Corp

The Site acknowledges that it has received, reviewed, and understands the MCTA and all Exhibits and Schedules thereto, and agrees to be bound by the terms and conditions thereof as if it were a direct party thereto, subject to the site-specific terms set forth herein

For avoidance of doubt, site-specific terms set forth in the Schedules to this Agreement that address matters of budget, enrollment allocation, and site-specific operational details shall not be deemed to conflict with the MCTA

Where an Exhibit or Schedule to this Agreement addresses the same subject matter as an Exhibit or Schedule to the MCTA, the two documents shall be read together and, to the extent practicable, harmonized

2 — Site Principal Investigator (a) The Site Principal Investigator for the Study at this Site shall be the individual identified in Schedule A to this Agreement